Key Insights

Highlights

Treatment Research

4 treatments under study, led by Selution Slr Dcb

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown1
Withdrawn1

Clinical Trials (2)

Showing 2 of 2 trials
NCT05450042Not ApplicableUnknown

Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation

NCT02237066Not ApplicableWithdrawnPrimary

Understanding Angioplasty by the Chocolate PTA Balloon Catheter Compared to Conventional PTA Balloons Via OCT Imaging

Showing all 2 trials

Research Network

Common Treatments

  • Selution Slr Dcb1
  • Chocolate Pta Balloon Angioplasty1
  • Paclitaxel Dcb1
  • Standard Pta Balloon Angioplasty1

Active Sponsors

  • University Hospitals Cleveland Medical Center1
  • University Hospital, Essen1
  • TriReme Medical, LLC1

Top Investigators

Related Conditions

  • Flowmediated Dilation1
  • Drug Eluting Balloon1
  • Peripheral Arterial Disease1

Activity Timeline